Becton, Dickinson and Company ( BDX ) Nowojorska Giełda Papierów Wartościowych

Cena: 176.16 ( -0.63% )

Aktualizacja 07-03 19:00
Nowojorska Giełda Papierów Wartościowych
Branża: Medical - Instruments & Supplies
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Instruments & Supplies
Zatrudnienie: 70 000
Giełda: Nowojorska Giełda Papierów Wartościowych
Ilość akcji w obrocie: 100%
Ilość akcji: 288 902 000
Debiut giełdowy: 1973-02-21
WWW: https://www.bd.com
CEO: Mr. Thomas E. Polen Jr.
Adres: 1 Becton Drive
Siedziba: 07417-1880 Franklin Lakes
ISIN: US0758871091
Opis firmy:

Becton, Dickinson and Company opracowują, produkuje i sprzedaje materiały medyczne, urządzenia, sprzęt laboratoryjny i produkty diagnostyczne dla instytucji opieki zdrowotnej, lekarzy, badaczy nauk o życiu, laboratoria kliniczne, przemysł farmaceutyczny i ogół społeczeństwa na całym świecie. Segment medyczny BD firmy oferuje obwodowe dożylne (IV) i zaawansowane cewniki obwodowe, linie centralne, ostre cewniki dializy, produkty do pielęgnacji naczyniowej i przygotowania, złącza igłowe IV i igły igłowe igłowe igłowe zestawy anestezjagowe i trafiły w kierunku strefysów, a strzałki i strefy. systemy; IV Systemy dostarczania leków i terapii infuzyjnej, leki komputerowe systemy przepływu pracy, automatyczne systemy dozowania i zarządzania dostawami oraz systemy optymalizacji zapasów i śledzenia zapasów leków; strzykawki, igły pióra i inne produkty do cukrzycy; oraz wstępne systemy dostarczania leków. Jego segment BD Life Sciences zapewnia okazy i produkty do zbierania krwi; Zautomatyzowana hodowanie krwi i gruźlicy, badania molekularne, identyfikacja mikroorganizmu i podatność na leki oraz systemy cytologii oparte na płynach, a także szybkie testy diagnostyczne, produkty do automatyzacji laboratorium mikrobiologii i produkty plastrowane; oraz fluorescencyjne sortowniki i analizatory komórkowe, przeciwciała i zestawy, systemy odczynników i roztwory do analizy ekspresji genów jednokomórkowych, a także odczynniki i analizy diagnostyczne/monitorowania monitorowania/monitorowania. Segment interwencyjny firmy BD oferuje przepuklinę i naprawę tkanek miękkich, biologiczne i bioresorbowalne przeszczepy, biochirurgia i inne produkty chirurgiczne; chirurgiczne zapobieganie infekcji, oprzyrządowanie chirurgiczne i laparoskopowe; produkty interwencyjne peryferyjne; oraz produkty urologii i opieki krytycznej. Firma została założona w 1897 roku i ma siedzibę w Franklin Lakes, New Jersey.

Wskaźniki finansowe
Kapitalizacja (USD) 50 488 689 120
Aktywa: 57 286 000 000
Cena: 176.16
Wskaźnik Altman Z-Score: 1.7
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 4
P/E: 34.1
Ilość akcji w obrocie: 100%
Średni wolumen: 3 086 037
Ilość akcji 286 607 000
Wskaźniki finansowe
Przychody TTM 20 178 000 000
Zobowiązania: 31 397 000 000
Przedział 52 tyg.: 163.33 - 251.99
Piotroski F-Score: 7
Silny (dobra jakość finansowa)
EPS: 5.2
P/E branży: 29.9
Beta: 0.45
Raport okresowy: 2025-08-07
WWW: https://www.bd.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Thomas E. Polen Jr. President, Chief Executive Officer & Chairman 3 460 875 1973
Ms. Shana Carol Neal Executive Vice President & Chief People Officer 1 785 400 1966
Mr. Michael Garrison Executive Vice President & President of Medical segment 1 728 832 1970
Mr. Christopher J. DelOrefice Executive Vice President & Chief Financial Officer 1 596 627 1972
Ms. Michelle Quinn Executive Vice President & General Counsel 0 1969
Mr. Thomas J. Spoerel Senior Vice President, Controller & Chief Accounting Officer 0 1979
Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D. Senior Vice President, Chief Scientific Officer & Co-Chair of Scientific Advisory Board 0 0
Mr. Greg Rodetis Head of Investor Relations 0 0
Ms. Denise Russell Fleming Executive Vice President of Technology & Global Services and Chief Information Officer 0 1970
Ms. Elizabeth McCombs Executive Vice President & Chief Technology Officer 0 1976
Wiadomości dla Becton, Dickinson and Company
Tytuł Treść Źródło Aktualizacja Link
UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025 These stocks have declined significantly in the past year and are now below their intrinsic values. 247wallst.com 2025-05-14 20:02:33 Czytaj oryginał (ang.)
Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript) Becton, Dickinson and Company (NYSE:BDX ) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Company Participants Tom Polen - Chairman, Chief Executive Officer and President Conference Call Participants Travis Steed - Bank of America Securities Travis Steed [Starts Abruptly] I'm Travis Steed, Medical Device Analyst at Bank of America and I'm fortunate to have Tom Polen up next, CEO at Becton, Dickinson. So welcome. seekingalpha.com 2025-05-14 01:44:30 Czytaj oryginał (ang.)
BD to Announce Financial Results for its Third Quarter of Fiscal 2025 FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. prnewswire.com 2025-05-12 13:00:00 Czytaj oryginał (ang.)
Buy 3 "Safer" Dividend Kings Of 25 From May's 55 The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kings, including Altria and Canadian Utilities, are now fairly priced, with annual dividends from $1K investments exceeding their single-share prices. Analysts predict net gains of 14.7% to 56.86% for the top ten Dividend Kings by yield for the coming year, based on target prices. Among the 55 Dividend Kings, 16 show negative free cash flow margins, making them cash-poor and unsafe for investment. seekingalpha.com 2025-05-06 16:58:48 Czytaj oryginał (ang.)
Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday. benzinga.com 2025-05-02 20:33:42 Czytaj oryginał (ang.)
9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next I'm going on a 2-week vacation with my family for my sister's wedding, so I've prepared a comprehensive article with three types of dividend aristocrat recommendations for whateveriscomingnext. Low-volatility aristocrats offer a 3.4% yield, a 46% downside capture ratio, and 52% less volatility than the S&P, making them ideal for addressing recession concerns while still providing a 23% return. High-yield aristocrats offer a 7% average yield with 11%-12% long-term return potential, providing low-risk income regardless of market or economic conditions. seekingalpha.com 2025-05-02 11:00:00 Czytaj oryginał (ang.)
Medical-products maker Becton Dickinson says cuts in global research funding have hurt sales Becton Dickinson & Co.'s stock fell more than 15% on Thursday toward its worst one-day loss in 26 years after the medical-products maker said global cuts in research funding are impacting its research instrument sales. marketwatch.com 2025-05-01 17:46:00 Czytaj oryginał (ang.)
William Blair downgrades Becton Dickinson on 'disappointing' Q2 update 01 May https://thefly.com 2025-05-01 16:15:46 Czytaj oryginał (ang.)
Becton, Dickinson and Company (BDX) Q2 2025 Earnings Call Transcript Becton, Dickinson and Company (NYSE:BDX ) Q2 2025 Results Conference Call May 1, 2025 8:00 AM ET Company Participants Greg Rodetis - Senior Vice President, Treasurer and Head of Investor Relations Tom Polen - Chairman, Chief Executive Officer and President Chris DelOrefice - Executive Vice President and Chief Financial Officer Mike Garrison - President of the Medical Mike Feld - President of the Life Sciences Rick Byrd - President of the Interventional Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Matt Taylor - Jefferies Travis Steed - Bank of America Patrick Wood - Morgan Stanley David Roman - Goldman Sachs Matt Miksic - Barclays Operator Hello, and welcome to BD's Second Fiscal Quarter 2025 Earnings Call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at (800) 839-2385 for domestic calls and area code +1-402-220-7203 for international calls. seekingalpha.com 2025-05-01 15:44:06 Czytaj oryginał (ang.)
Becton Dickinson (BDX) Reports Q2 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-05-01 14:36:32 Czytaj oryginał (ang.)
Cramer's Stop Trading: Becton Dickinson CNBC's Jim Cramer explains why he is keeping an eye on shares of Becton Dickinson. youtube.com 2025-05-01 14:22:44 Czytaj oryginał (ang.)
Becton Dickinson (BDX) Q2 Earnings Top Estimates Becton Dickinson (BDX) came out with quarterly earnings of $3.35 per share, beating the Zacks Consensus Estimate of $3.28 per share. This compares to earnings of $3.17 per share a year ago. zacks.com 2025-05-01 12:45:44 Czytaj oryginał (ang.)
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit Medical device maker Becton Dickinson lowered its annual profit forecast on Thursday, in anticipation of a potential hit from U.S. President Donald Trump's tariffs, sending its shares down 5% in premarket trading. reuters.com 2025-05-01 11:48:47 Czytaj oryginał (ang.)
BD Reports Second Quarter Fiscal 2025 Financial Results Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic GAAP and adjusted diluted EPS of $1.07 and $3.35, respectively Company updates full-year fiscal 2025 guidance and provides estimated tariff impact FRANKLIN LAKES, N.J., May 1, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2025 second quarter, which ended March 31, 2025. prnewswire.com 2025-05-01 10:30:00 Czytaj oryginał (ang.)
BD to Present at Bank of America Securities Health Care Conference FRANKLIN LAKES, N.J. , April 30, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Bank of America Securities Health Care Conference on Tuesday, May 13, 2025 at 1:00 pm Eastern Time. prnewswire.com 2025-04-30 20:15:00 Czytaj oryginał (ang.)
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues. zacks.com 2025-04-30 15:55:39 Czytaj oryginał (ang.)
Best Dividend Aristocrats For May 2025 Despite a strong start, the Dividend Aristocrats are underperforming the S&P 500 in April, with NOBL down 4.88% and SPY down 1.53%. The best-performing Dividend Aristocrats YTD include Consolidated Edison (+25.65%), Cardinal Health (+17.82%), and Coca-Cola (+16.18%). 33 out of 69 Dividend Aristocrats have announced dividend increases in 2025, with an average growth rate of 4.33%. seekingalpha.com 2025-04-30 00:07:22 Czytaj oryginał (ang.)
BD Board Declares Dividend FRANKLIN LAKES, N.J. , April 29, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, payable on June 30, 2025 to holders of record on June 9, 2025. prnewswire.com 2025-04-29 20:20:00 Czytaj oryginał (ang.)
Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings? The continued solid uptake of BD's products is expected to have driven fiscal second-quarter revenues despite transitory market dynamics. zacks.com 2025-04-28 17:20:40 Czytaj oryginał (ang.)
Gear Up for Becton Dickinson (BDX) Q2 Earnings: Wall Street Estimates for Key Metrics Besides Wall Street's top -and-bottom-line estimates for Becton Dickinson (BDX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025. zacks.com 2025-04-28 14:21:40 Czytaj oryginał (ang.)
Becton Dickinson (BDX) is a Top-Ranked Value Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com 2025-01-03 12:46:04 Czytaj oryginał (ang.)
BDX vs. MMSI: Which Stock Is the Better Value Option? Investors interested in Medical - Dental Supplies stocks are likely familiar with Becton Dickinson (BDX) and Merit Medical (MMSI). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-01-01 14:51:07 Czytaj oryginał (ang.)
My Best Dividend Aristocrats For January 2025 The ProShares S&P 500 Dividend Aristocrat ETF rocked a cool 4.85% gain in November, but it's giving up nearly half of its return this year in December. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 41 months of tracking these strategies, two strategies are generating a CAGR superior to NOBL. seekingalpha.com 2024-12-31 08:47:18 Czytaj oryginał (ang.)
5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care. zacks.com 2024-12-30 10:31:10 Czytaj oryginał (ang.)
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-12-20 12:46:33 Czytaj oryginał (ang.)
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing The blood testing process integrating BD's MiniDraw System with Babson's BetterWay technologies is likely to lower common barriers to testing and improve patient outcomes. zacks.com 2024-12-18 13:46:10 Czytaj oryginał (ang.)
Here's Why Becton Dickinson (BDX) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2024-12-18 12:40:31 Czytaj oryginał (ang.)
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2024-12-17 12:51:31 Czytaj oryginał (ang.)
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations FRANKLIN LAKES, N.J. and AUSTIN, Texas , Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings. prnewswire.com 2024-12-17 08:50:00 Czytaj oryginał (ang.)
Becton Dickinson settles charges over infusion pump risks, SEC says The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. over allegations it misled investors about risks associated with its Alaris infusion pump. reuters.com 2024-12-16 18:46:40 Czytaj oryginał (ang.)
Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump Washington, D.C.--(Newsfile Corp. - December 16, 2024) - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and Company, a New Jersey-based medical device manufacturer known as BD, for repeatedly misleading investors about risks associated with its continued sales of its Alaris infusion pump and for overstating its income by failing to record the costs of fixing multiple software flaws with the pump. newsfilecorp.com 2024-12-16 18:38:00 Czytaj oryginał (ang.)
BD Resolves Previously Disclosed SEC Investigation FRANKLIN LAKES, N.J. , Dec. 16, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement: BD has reached an agreement with the U.S. Securities and Exchange Commission (SEC) to resolve the previously disclosed investigation related to prior public disclosures and SEC reporting regarding the BD Alaris™ System, which was acquired by BD from CareFusion in 2015 and is part of the BD Medication Management Solutions business. prnewswire.com 2024-12-16 18:32:00 Czytaj oryginał (ang.)
Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article. zacks.com 2024-12-13 05:15:24 Czytaj oryginał (ang.)
4 Stocks to Watch Amid Dental Supplies Industry Challenges Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are BDX, MCK, CAH and MMSI. zacks.com 2024-12-12 11:46:09 Czytaj oryginał (ang.)
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025 Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance Health, Becton, Dickinson, LyondellBasell, Rogers Communications and Rexford Industrial Realty. These companies offer a 3.7% yield and a 27% discount to fair value, and they have historically outperformed the market with 27% less volatility. seekingalpha.com 2024-12-12 09:00:00 Czytaj oryginał (ang.)
12 High-Yield Dividend Aristocrats To Weather The Coming 2025 Storm In Style The S&P is up almost 28% in 2024, and many investors worry about a melt-up followed by a sharp correction like in 2022 or 2018. A 2025 market correction is likely, but low-volatility, high-yield Dividend Aristocrats offer a better alternative to the traditional 60-40 portfolio and S&P. These 12 Aristocrats provide a 3.2% yield, 14% discount, 22% upside potential next year, and 10% long-term income growth consensus, while being 54% lower volatility than the S&P. seekingalpha.com 2024-12-07 09:00:00 Czytaj oryginał (ang.)
These 5 Stocks Have 50 Years of Dividend Growth—Here's How to Find More With a new presidential administration set to take office on Jan. 20, 2025, some investors may be uncertain about how new policies and personnel will affect the stock market and interest rates. Will tariffs, discarded trade deals, and frayed alliances help or hurt the market? investopedia.com 2024-12-06 16:10:45 Czytaj oryginał (ang.)
17 Upcoming Dividend Increases, Including A King With the holiday season underway, I present 17 companies with dividend increases for 2024, including Becton, Dickinson, and Company, a dividend king with a 52-year streak. My strategy focuses on buying, holding, and adding to companies with consistent dividend growth and outperforming benchmarks, using data from U.S. Dividend Champions and NASDAQ. I prioritize companies with strong historical returns and high 10-year dividend growth rates, comparing them against the Schwab U.S. Dividend Equity ETF. seekingalpha.com 2024-12-05 13:08:55 Czytaj oryginał (ang.)
Becton, Dickinson and Company (BDX) 7th Annual Evercore ISI HealthCONx Conference (Transcript) Becton, Dickinson and Company (NYSE:BDX ) 7th Annual Evercore ISI HealthCONx Results Conference December 3, 2024 10:50 AM ET Company Participants Richard Byrd - EVP and President of Interventional Business Chris DelOrefice - Executive Vice President & Chief Financial Officer Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar Thanks, everyone, for joining us this morning. A pleasure to have with us Becton, Dickinson. seekingalpha.com 2024-12-03 16:14:06 Czytaj oryginał (ang.)
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com 2024-12-02 17:26:17 Czytaj oryginał (ang.)